Investor Relations

News Releases

Date Title and Summary Additional Formats
Toggle Summary Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer
BEDFORD, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) announced today with great sadness that Joseph Darling, its President and Chief Executive Officer, passed away unexpectedly on January 29, 2020 in Upstate New York. He was 62.
View HTML
Toggle Summary Anika Therapeutics Closes Acquisition of Parcus Medical
Transaction Accelerates Anika’s Revenue Growth, Broadens Joint Preservation and Restoration Product Portfolio, Enhances Commercial Capabilities and Expands Pipeline BEDFORD, Mass. , Jan. 24, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc.  (NASDAQ: ANIK), a global, integrated joint preservation
View HTML
Toggle Summary Anika Therapeutics to Acquire Parcus Medical and Arthrosurface
Accelerates Revenue Growth through Broadened Joint Preservation and Restoration Product Portfolio, Enhances Commercial Capabilities, and Expands Pipeline Conference Call & Webcast January 8 at 8:30 a.m. ET BEDFORD, Mass. --(BUSINESS WIRE)--Jan. 6, 2020-- Anika Therapeutics, Inc.
View HTML
Toggle Summary Anika Commences Full U.S. Commercial Launch of TACTOSET Bone Repair Therapy at Orthopaedic Summit 2019: Evolving Techniques
BEDFORD, Mass. --(BUSINESS WIRE)--Dec. 10, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform , today announced it will commence the full U.S.
View HTML
Toggle Summary Anika Therapeutics Announces Participation in MEDICA International Trade Fair and International Cartilage Regeneration and Joint Preservation Society Focus Meeting
BEDFORD, Mass. --(BUSINESS WIRE)--Nov. 15, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform , today announced its participation in two upcoming
View HTML
Toggle Summary Anika to Showcase Joint Preservation and Restoration Portfolio at the 2019 Fortius International Sports Injury Conference
BEDFORD, Mass. --(BUSINESS WIRE)--Nov. 5, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid ("HA") technology platform , today announced plans to showcase its
View HTML
Toggle Summary Anika Reports Third Quarter 2019 Financial Results
Total Revenue Increases 11% and Net Income Increases 21% Year-over-Year Company Raises Full Year 2019 Revenue and Earnings Guidance Executing Five-Year Strategic Plan Focused on Joint Preservation and Restoration BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 24, 2019-- Anika Therapeutics, Inc.
View HTML
Toggle Summary Anika to Showcase Joint Preservation and Restoration Portfolio at the Annual Scientific Meeting of the International Society for Hip Arthroscopy
BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 16, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid ("HA") technology platform , today announced plans to showcase its
View HTML
Toggle Summary Anika Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality, and Clinical Affairs
Industry veteran brings extensive experience leading global regulatory, quality, and clinical affairs teams BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 14, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated company, focused on developing regenerative therapies leveraging its
View HTML
Toggle Summary Anika to Issue Third-quarter 2019 Financial Results and Business Highlights on Thursday, October 24
  BEDFORD, Mass. --(BUSINESS WIRE)--Oct. 10, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its third-quarter 2019 financial results after the close of the market on Thursday, October 24, 2019 and hold its investor conference call on the same day,
View HTML